BofA/Merrill Lynch Starts Surgery Partners (SGRY) at Buy
Tweet
Share
E-mailGet Alerts SGRY Hot Sheet
Price: $14.55 --0%
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
BofA/Merrill Lynch initiated coverage on Surgery Partners (NASDAQ: SGRY) with a Buy rating and a price target of $27.00.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $17.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Deutsche Bank Starts Insulet Corporation (PODD) at Buy
- H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
